Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

N-salicyloyl tryptamine derivatives as potential therapeutic agents for Alzheimer's disease with neuroprotective effects
Yinliang Bai, Dan Liu, Honghua Zhang, et al.
Bioorganic Chemistry (2021) Vol. 115, pp. 105255-105255
Closed Access | Times Cited: 25

Showing 25 citing articles:

Puerarin: a potential natural neuroprotective agent for neurological disorders
Xue Liu, Rui Huang, Jiye Wan
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114581-114581
Open Access | Times Cited: 46
Pyroptosis in health and disease: mechanisms, regulation and clinical perspective
Yifan Liu, Renjie Pan, Yuzhen Ouyang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease
Honghua Zhang, Yuying Wang, Yuqing Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114606-114606
Closed Access | Times Cited: 55
RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 14
Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease
Dan Liu, Honghua Zhang, Yuying Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 114044-114044
Closed Access | Times Cited: 45
Pyroptosis in neurodegenerative diseases: from bench to bedside
Kejia Wu, Wan-rong Wang, Qian-hui Cheng, et al.
Cell Biology and Toxicology (2023) Vol. 39, Iss. 6, pp. 2467-2499
Closed Access | Times Cited: 17
Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
Yuehua Huang, Xiaoyü Li, Guifei Luo, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 23
Carbamate-based N-Substituted tryptamine derivatives as novel pleiotropic molecules for Alzheimer's disease
Honghua Zhang, Yuying Wang, Dan Liu, et al.
Bioorganic Chemistry (2022) Vol. 125, pp. 105844-105844
Closed Access | Times Cited: 19
The role of pyroptosis in cognitive impairment
Xin Yang, Zhe Tang
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 11
Tryptamine: A privileged scaffold for the management of Alzheimer's disease
Yash Pal Singh, Harish Kumar
Drug Development Research (2023) Vol. 84, Iss. 8, pp. 1578-1594
Closed Access | Times Cited: 11
N-Salicyloyl Tryptamine Derivatives as Potent Neuroinflammation Inhibitors by Constraining Microglia Activation via a STAT3 Pathway
Yuting Zhao, Yan Peng, Xiuzhen Wei, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 13, pp. 2484-2503
Closed Access | Times Cited: 4
Targeting UAF1 Alleviate Neurotoxicity by Inhibiting APP/NLRP3 Axis-Mediated Pyroptosis and Apoptosis
Ling Cheng, Xianguang Meng, Dandan Tian, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Open Access
Design and development of sulfenylated 5-aminopyrazoles as inhibitors of acetylcholinesterase and butyrylcholinesterase: exploring the implication for Aβ1–42 aggregation inhibition in Alzheimer's disease
Payal Rani, Sandhya Chahal, Anju Ranolia, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Design, synthesis and biological evaluation of N-salicyloyl tryptamine derivatives as multifunctional neuroprotectants for the treatment of ischemic stroke
Genping Wu, Bo Li, Xiuzhen Wei, et al.
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116795-116795
Closed Access | Times Cited: 3
Discovery of carbamate-based N-salicyloyl tryptamine derivatives as novel pleiotropic agents for the treatment of Alzheimer's disease
Yuying Wang, Honghua Zhang, Dan Liu, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105993-105993
Closed Access | Times Cited: 15
Synthesis of new multitarget-directed ligands containing thienopyrimidine nucleus for inhibition of 15-lipoxygenase, cyclooxygenases, and pro-inflammatory cytokines
Ahmed S. Abdelkhalek, Hend Kothayer, Samar Rezq, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115443-115443
Closed Access | Times Cited: 7
Neuroprotective Effects of an N-Salicyloyl Tryptamine Derivative against Cerebral Ischemia/Reperfusion Injury
Jian-Hui Su, Genping Wu, Peng Xue, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 2146-2158
Closed Access | Times Cited: 6
Pocahemiketone A, a Sesquiterpenoid Possessing a Spirocyclic Skeleton with a Hemiketal Endoperoxide Unit, Alleviates Aβ25–35-Induced Pyroptosis and Oxidative Stress in SH-SY5Y Cells
Qin‐Mei Zhou, Haoyu Zhao, Chuan Ma, et al.
Organic Letters (2022) Vol. 24, Iss. 26, pp. 4734-4738
Closed Access | Times Cited: 9
Synthesis and biological evaluation of capsaicin analogues as antioxidant and neuroprotective agents
Mao Xie, Huixian Wu, Jing Bian, et al.
RSC Advances (2023) Vol. 13, Iss. 46, pp. 32150-32159
Open Access | Times Cited: 5
Design and synthesis of salidroside analogs and their bioactivity against septic myocardial injury
Zongyuan Wang, Xin Qiang, Chunyi Peng, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106609-106609
Closed Access | Times Cited: 4
Exploring the Therapeutic Effects of Multifunctional N-Salicylic Acid Tryptamine Derivative against Parkinson’s Disease
Xuelin Li, Shuzhi Wang, Shan Duan, et al.
ACS Omega (2023) Vol. 8, Iss. 31, pp. 28910-28923
Open Access | Times Cited: 4
The Role of Pyroptosis in Alzheimer's Disease
Yanxiu Ju, Ling Zhao, Songtao Li, et al.
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 5, pp. 129-129
Open Access | Times Cited: 4
Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer’s disease
Gauri Shankar, Prabhat Kumar, Sanskriti Rai, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117066-117066
Closed Access | Times Cited: 1
Identification of Molecular Correlations of GSDMD with Pyroptosis in Alzheimer's Disease
Tangtang Song, Yan Chen, Chen Li, et al.
Combinatorial Chemistry & High Throughput Screening (2024) Vol. 27, Iss. 14, pp. 2125-2139
Closed Access
Different amyloid β42 preparations induce different cell death pathways in the model of SH-SY5Y neuroblastoma cells
Alp Yiğit Özdemir, Kateřina Hofbauerová, Vladimı́r Kopecký, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access
Page 1

Scroll to top